Skip to content
HCN Grants Est. 2026
No. RFA-FD-25-017 · Food and Drug Administration
Open

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated

At a glance

No plain-language summary yet for this grant — the official description below is the best source.

What it funds

  • Agriculture
  • Consumer Protection
  • Food and Nutrition
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.

Who can apply

  • Others
Geographic restriction None found in the announcement — likely nationwide